SCHEMBL29863385

SCHEMBL29863385

COc1cc(C)c(CCN(C)C)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.41
NNMT P40261 1/20 0.41
HTR6 P50406 3/20 0.36
HTR1A P08908 2/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR2C P28335 1/20 0.36
HTR1E P28566 1/20 0.36
HTR1F P30939 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
HTR3A P46098 1/20 0.36
HTR5A P47898 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21459468 1.00 HTR2A (0.41) HTR2ANNMTHTR6HTR1AHTR3E
SCHEMBL23257404 0.86 HTR2A (0.41) HTR2ANNMT
SCHEMBL18396986 0.79 NNMT (0.44) NNMTMTNR1AMTNR1BNOS1
SCHEMBL29610740 0.78 GAA (0.43) HTR2AHTR6HTR1AHTR2C
SCHEMBL21459396 0.78 GAA (0.43) HTR2AHTR6HTR1AHTR2C
SCHEMBL31088804 0.78 HTR2A (0.38) HTR2AHTR6HTR1AHTR3EHTR3B
SCHEMBL31089206 0.77 HTR2A (0.37) HTR2AHTR6HTR1AHTR3EHTR3B
SCHEMBL10263430 0.77 NOS3 (0.55) NNMTL3MBTL1NOS1
SCHEMBL1922545 0.77 NNMT (0.45) NNMTMTNR1AMTNR1BNOS1
SCHEMBL21459479 0.76 HTR7 (0.37) HTR2AHTR6HTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024175907-A1 MACROCYCLIC ALPHA4BETA7 INTEGRIN INHIBITORS C4X DISCOVERY LIMITED (GB) 2024-08-29 WO disclosed
EP-4045039-A1 INHIBITING HUMAN INTEGRIN ALPHA4BETA7 Morphic Therapeutic, Inc. (US) 2022-08-24 EP disclosed